Investigator
Senior Scientist · Regeneron Pharmaceuticals
Predicting endometrial cancer subtypes and molecular features from histopathology images using multi-resolution deep learning models
The determination of endometrial carcinoma histological subtypes, molecular subtypes, and mutation status is critical for the diagnostic process, and directly affects patients' prognosis and treatment. Sequencing, albeit slower and more expensive, can provide additional information on molecular subtypes and mutations that can be used to better select treatments. Here, we implement a customized multi-resolution deep convolutional neural network, Panoptes, that predicts not only the histological subtypes but also the molecular subtypes and 18 common gene mutations based on digitized H&E-stained pathological images. The model achieves high accuracy and generalizes well on independent datasets. Our results suggest that Panoptes, with further refinement, has the potential for clinical application to help pathologists determine molecular subtypes and mutations of endometrial carcinoma without sequencing.
Senior Scientist
Regeneron Pharmaceuticals
Senior Data Scientist
Boston Consulting Group · BCG GAMMA
Graduate Assistant
NYU Langone Health · Institute for Systems Genetics
RWE Data Scientist (intern)
Novartis Pharmaceuticals Corporation · Oncology
Research Assistant (intern)
European Molecular Biology Laboratory · Structural and Computational Biology
Scopus: 57212681163
Researcher Id: AAY-5767-2021